NORML
Since its founding in 1970, NORML has provided a voice in the public policy debate for those Americans who oppose marijuana prohibition and favor an end to the practice of arresting marijuana smokers. A nonprofit public-interest advocacy group, NORML represents the interests of the tens of millions of Americans who smoke marijuana responsibly.
Because NORML lobbies state and federal legislators, donations to NORML are not tax deductible.
During the 1970s, NORML led the successful efforts to decriminalize minor marijuana offenses in 11 states and significantly lower marijuana penalties in all others.
Today NORML continues to lead the fight to reform state and federal marijuana laws, whether by voter initiative or through the elected legislatures. NORML serves as an informational resource to the national media on marijuana-related stories, providing a perspective to offset the anti-marijuana propaganda from the government; lobbies state and federal legislators in support of reform legislation; publishes a regular newsletter; hosts, along with the NORML Foundation, an informative web site and an annual conference; and serves as the umbrella group for a national network of citizen-activists committed to ending marijuana prohibition and legalizing marijuana.
Our sister organization, the NORML Foundation sponsors public advertising campaigns to better educate the public about marijuana and alternatives to current marijuana policy; provides legal assistance and support to victims of the current laws; and undertakes relevant research.
The oldest and largest marijuana legalization organization in the country, NORML maintains a professional staff in Washington, DC, headed by Executive Director Erik Altieri, and a network of volunteer state and local NORML Chapters across the country.
Featured NORML CBD Articles
- Analysis: Most Commercially Available CBD Products Mislabeled, Make Misleading Claims
- Analysis: Many ‘Hemp-Derived’ Delta-9 THC Products Sold Over the Counter Contain Synthetically Derived THC
- CBD Products Commonly Flagged by FDA for Making Unsubstantiated Claims About Treating COVID-19
- Clinical Trial: Whole-Plant Cannabis Extracts Associated with Improved Outcomes in Autistic Patients
- Study: Subjects Report Reduced Symptoms of Obsessive-Compulsive Disorder Following Cannabis Inhalation
- Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent
- Review Paper: Clinical Evidence Lacking in Support of CBD as an Anti-Viral Agent
- A NORML Reminder: Beware of COVID-19 Cure All Claims
- A NORML Reminder: Beware of COVID-19 Cure All Claims
- Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain
- Clinical Trial: Transdermal Application of CBD Effective in Patients with Myofascial Pain
- FDA Sends Warning Letters to Multiple Companies for Illegally Marketing CBD Products
- FDA Sends Warning Letters to Multiple Companies for Illegally Marketing CBD Products
- Report: Potency of CBD Products Sold Online Often Deviates From What Is Advertised
- Report: Potency of CBD Products Sold Online Often Deviates From What Is Advertised
BEST CBD PRODUCTS
Uncut CBD Dab Syringes
Uncut CBD Dab Syringes
Uncut CBD Dab Syringes
Uncut CBD Dab Syringes
CBD Isolate Tinctures (0.00% THC)
Dark CBD Softgels
Uncut Disposable CBD Vape Pens
Uncut Disposable CBD Vape Pens
CBD Isolate Tinctures (0.00% THC)
Uncut Disposable CBD Vape Pens
Uncut Disposable CBD Vape Pens
Uncut Disposable CBD Vape Pens
Uncut Disposable CBD Vape Pens
Uncut Disposable CBD Vape Pens
Uncut Disposable CBD Vape Pens
Unrefined CBD Topicals
Uncut CBD Vape Cartridges
Uncut CBD Vape Cartridges
Dark CBD Tinctures
Dark CBD Gummies
Gummy NOIDS™ DARK FULL SPECTRUM Gummies – 600mg CBD (24 pieces)
